Published in Cancer Weekly, December 7th, 2004
The 181 patients in the study group - consecutive, postmenopausal, breast cancer patients scheduled to start endocrine treatment - completed at the beginning of their participation a questionnaire on menopausal symptoms, including vasomotor, atrophic, psychological, cognitive, and...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Cancer Weekly
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.